Moreover, this study may explain the imbalance between ERAP1 and ERAP2 observed in various tumor cell lines, such as leukemia, lymphoma, carcinoma, and melanoma [101], and in tumor-transformed tissues of the breast, ovary, lung, colon, and thyroid [102]. This evidence concerns the gene ERAP2 and carcinoma.